MediciNova Inc
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California. Show More...
-
Website https://www.medicinova.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 1.39 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -1.63 -1.2 -0.66 -0.19 -0.38 -0.33 -0.33 -0.32 -0.36 -0.3 -0.25 Dividends USD Payout Ratio % * Shares Mil 12.0 15.0 17.0 21.0 24.0 27.0 33.0 35.0 41.0 43.0 44.0 Book Value Per Share * USD 1.98 1.2 0.85 0.95 0.94 1.16 1.04 0.95 1.75 1.69 1.66 Free Cash Flow Per Share * USD -1.43 -1.15 -0.72 -0.46 -0.09 -0.22 -0.22 -0.2 -0.21 -0.2 Return on Assets % -24.14 -34.2 -43.54 -16.4 -32.37 -27.14 -27.96 -26.82 -24.33 -16.55 -14.09 Financial Leverage (Average) 2.95 1.31 1.32 1.16 1.24 1.16 1.15 1.12 1.06 1.06 1.05 Return on Equity % -62.39 -73.59 -57.13 -19.99 -38.77 -32.31 -32.3 -30.51 -26.26 -17.49 -14.78 Return on Invested Capital % -24.62 -69.28 -57.13 -19.99 -38.77 -32.3 -32.3 -30.51 -27.95 -18.62 -16.22 Interest Coverage -10.41 -10.11 Current Ratio 1.59 4.25 4.26 31.23 7.61 15.25 15.15 9.83 28.63 28.86 34.64 Quick Ratio 0.78 4.08 3.86 27.6 7.32 14.81 14.8 9.72 28.43 28.63 34.17 Debt/Equity 0.38